Latest DEF 14A proxy statements

i-80 Gold Corp. has issued its proxy statement detailing the upcoming Annual General Meeting on June 23, 2026, outlining proposals for director elections, auditor appointment, and financial statement review.

Orthofix Medical Inc. has issued its 2026 Proxy Statement detailing the upcoming Annual Meeting of Shareholders on June 10, 2026, outlining proposals for director elections, executive compensation, auditor ratification, and stock purchase plan amendments.

Penumbra, Inc. has announced its 2026 Annual Meeting of Stockholders and a definitive merger agreement with Boston Scientific Corporation.

Sensata Technologies Holding plc has released its 2026 Proxy Statement detailing the upcoming Annual General Meeting of Shareholders on June 9, 2026, outlining proposals for director elections, executive compensation, auditor ratification, and corporate governance matters.

CorMedix Inc. is holding its 2026 Annual Meeting of Stockholders on June 23, 2026, to vote on several proposals, including director elections, executive compensation, auditor ratification, and significant amendments to its corporate charter and preferred stock designations.

Crinetics Pharmaceuticals, Inc. has announced its 2026 Annual Meeting of Shareholders, scheduled for June 18, 2026, to elect directors, ratify auditor selection, and vote on executive compensation.

Sensus Healthcare, Inc. has issued its definitive proxy statement, announcing the 2026 Annual Meeting of Stockholders scheduled for May 29, 2026, to elect directors and vote on executive compensation.

Generac Holdings Inc. has filed its 2026 Proxy Statement, detailing the agenda for its Annual Meeting of Stockholders on June 11, 2026, including director elections, auditor ratification, and advisory executive compensation approval.

Fidelity National Financial, Inc. has announced its 2026 Annual Meeting of Shareholders will be held virtually on June 10, 2026, to elect directors and vote on key corporate matters.

Axogen, Inc. announced its 2026 Annual Meeting of Shareholders will be held virtually on June 23, 2026, to elect directors, ratify auditors, and vote on executive compensation.

SANUWAVE Health, Inc. has announced its annual stockholder meeting for June 11, 2026, to vote on director elections, auditor ratification, and executive compensation.

Candel Therapeutics, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 23, 2026, to elect directors and ratify auditor appointment.

Cypherpunk Technologies Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 18, 2026, to elect directors, vote on executive compensation, and ratify auditor appointments.

IDEAYA Biosciences, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 16, 2026, to elect directors, ratify auditor selection, and vote on executive compensation.

Xometry announces record $687 million in revenue for 2025, a 26% year-over-year increase, alongside significant Adjusted EBITDA growth and marketplace gross margin expansion.

Black Diamond Therapeutics, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 26, 2026, to elect directors, ratify auditors, and vote on executive compensation.

Adicet Bio, Inc. announces its 2026 Annual Meeting of Stockholders to be held virtually on June 17, 2026, with key proposals including director elections and executive compensation.

SenesTech, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 9, 2026, to elect directors, vote on executive compensation, and approve an amendment to its 2018 Equity Incentive Plan.

Usio, Inc. has issued its definitive proxy statement for the 2026 Annual Stockholder Meeting, scheduled for June 10, 2026, detailing proposals for director elections, executive compensation, and auditor ratification.

ARS Pharmaceuticals announces its 2026 Annual Meeting of Stockholders, scheduled for June 24, 2026, and provides an update on the successful commercial launch of its needle-free epinephrine nasal spray, neffy.

LanzaTech Global announces its 2026 Annual Meeting of Stockholders, detailing director elections, auditor ratification, and executive compensation.

AbCellera Biologics Inc. has announced its 2026 Annual Meeting of Shareholders will be held virtually on June 11, 2026, to elect directors, ratify auditor appointment, and vote on executive compensation.

Terex Corporation has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 25, 2026, detailing director nominations, executive compensation, and incentive plans.

Solitario Resources Corp. has issued a proxy statement detailing its upcoming Annual Meeting of Shareholders on June 17, 2026, focusing on director elections, executive compensation, and auditor ratification.

Hawaiian Electric Industries (HEI) announced its 2026 Annual Meeting of Shareholders, to be held virtually on June 11, 2026, detailing director nominations and executive compensation.

HCW Biologics Inc. is holding its 2026 Annual Meeting of Stockholders on June 15, 2026, to vote on director elections, auditor ratification, a reverse stock split, and warrant proposals.

OFS Capital Corporation is holding a special meeting on June 10, 2026, to seek stockholder approval for a proposal allowing the company to issue shares of its common stock at a price below its net asset value (NAV) under certain conditions.

Titan Machinery Inc. announces its 2026 Annual Meeting of Stockholders to be held virtually on June 8, 2026, with key proposals including director elections and executive compensation.

Evolus, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 11, 2026, to be held virtually via live webcast.

Arvinas, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 24, 2026, to elect directors, vote on executive compensation, and ratify auditor appointment.